Helicobacter Pylori Induces an Antimicrobial Response in Rhesus Macaques in a Cag Pathogenicity Island-dependent Manner

Overview

Journal Gastroenterology

Specialty Gastroenterology

Date 2008 Apr 9

PMID 18395086

Citations 38

Authors

Michael J Hornsby

Jennifer L Huff

Robert J Kays

Don R Canfield

Charles L Bevins

Jay V Solnick

Affiliations

Soon will be listed here.

Abstract

Background & Aims: We used the rhesus macaque model to study the effects of the cag pathogenicity island (cag PAI) on the H pylori host-pathogen interaction.

Methods: H pylori-specific pathogen-free (SPF) monkeys were experimentally challenged with wild-type (WT) H pylori strain J166 (J166WT, n = 4) or its cag PAI isogenic knockout (J166Deltacag PAI, n = 4). Animals underwent endoscopy before and 1, 4, 8, and 13 weeks after challenge. Gastric biopsies were collected for quantitative culture, histopathology, and host gene expression analysis.

Results: Quantitative cultures showed that all experimentally challenged animals were infected with J166WT or its isogenic J166Deltacag PAI. Histopathology demonstrated that inflammation and expansion of the lamina propria were attenuated in animals infected with J166Deltacag PAI compared with J166WT. Microarray analysis showed that of the 119 up-regulated genes in the J166WT-infected animals, several encode innate antimicrobial effector proteins, including elafin, siderocalin, DMBT1, DUOX2, and several novel paralogues of human-beta defensin-2. Quantitative RT-PCR confirmed that high-level induction of each of these genes depended on the presence of the cag PAI. Immunohistochemistry confirmed increased human-beta defensin-2 epithelial cell staining in animals challenged with J166WT compared with either J166Deltacag PAI-challenged or uninfected control animals.

Conclusions: We propose that one function of the cag PAI is to induce an antimicrobial host response that may serve to increase the competitive advantage of H pylori in the gastric niche and could even provide a protective benefit to the host.

Citing Articles

in Inflammatory Bowel Diseases: Active Protagonist or Innocent Bystander?.

Bretto E, Frara S, Armandi A, Caviglia G, Saracco G, Bugianesi E Antibiotics (Basel). 2024; 13(3).

PMID: 38534702 PMC: 10967592. DOI: 10.3390/antibiotics13030267.

The pathogenicity island as a determinant of gastric cancer risk.

Tran S, Bryant K, Cover T Gut Microbes. 2024; 16(1):2314201.

PMID: 38391242 PMC: 10896142. DOI: 10.1080/19490976.2024.2314201.

Maintenance of Type IV Secretion Function During Helicobacter pylori Infection in Mice.

Skoog E, Martin M, Barrozo R, Hansen L, Cai L, Lee S mBio. 2021; 11(6).

PMID: 33443133 PMC: 8534286. DOI: 10.1128/mBio.03147-20.

Gut microbiota shifts in patients with gastric cancer in perioperative period.

Liang W, Yang Y, Wang H, Wang H, Yu X, Lu Y Medicine (Baltimore). 2019; 98(35):e16626.

PMID: 31464899 PMC: 6736490. DOI: 10.1097/MD.0000000000016626.

Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease.

Tepler A, Narula N, Peek Jr R, Patel A, Edelson C, Colombel J Aliment Pharmacol Ther. 2019; 50(2):121-131.

PMID: 31165513 PMC: 7393806. DOI: 10.1111/apt.15306.

References

Sicinschi L, Correa P, Bravo L, Schneider B . A positive assay for identification of cagA negative strains of Helicobacter pylori. J Microbiol Methods. 2003; 55(3):625-33. DOI: 10.1016/s0167-7012(03)00206-9. View

Valore E, Wiley D, Ganz T . Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis. Infect Immun. 2006; 74(10):5693-702. PMC: 1594936. DOI: 10.1128/IAI.00524-06. View

Kao C, Chen Y, Thai P, Wachi S, Huang F, Kim C . IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J Immunol. 2004; 173(5):3482-91. DOI: 10.4049/jimmunol.173.5.3482. View

Hamanaka Y, Nakashima M, Wada A, Ito M, Kurazono H, Hojo H . Expression of human beta-defensin 2 (hBD-2) in Helicobacter pylori induced gastritis: antibacterial effect of hBD-2 against Helicobacter pylori. Gut. 2001; 49(4):481-7. PMC: 1728463. DOI: 10.1136/gut.49.4.481. View

ONeil D, Cole S, Housley M, Liu L, Ganz T, Kagnoff M . Regulation of human beta-defensins by gastric epithelial cells in response to infection with Helicobacter pylori or stimulation with interleukin-1. Infect Immun. 2000; 68(9):5412-5. PMC: 101807. DOI: 10.1128/IAI.68.9.5412-5415.2000. View

Chen Y, Blaser M . Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med. 2007; 167(8):821-7. DOI: 10.1001/archinte.167.8.821. View

Williams S, Brown T, Roghanian A, Sallenave J . SLPI and elafin: one glove, many fingers. Clin Sci (Lond). 2005; 110(1):21-35. DOI: 10.1042/CS20050115. View

Khamri W, Moran A, Worku M, Karim Q, Walker M, Annuk H . Variations in Helicobacter pylori lipopolysaccharide to evade the innate immune component surfactant protein D. Infect Immun. 2005; 73(11):7677-86. PMC: 1273859. DOI: 10.1128/IAI.73.11.7677-7686.2005. View

Yamazaki S, Yamakawa A, Ito Y, Ohtani M, Higashi H, Hatakeyama M . The CagA protein of Helicobacter pylori is translocated into epithelial cells and binds to SHP-2 in human gastric mucosa. J Infect Dis. 2003; 187(2):334-7. DOI: 10.1086/367807. View

10.

Crabtree J, Covacci A, Farmery S, Xiang Z, Tompkins D, Perry S . Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J Clin Pathol. 1995; 48(1):41-5. PMC: 502260. DOI: 10.1136/jcp.48.1.41. View

11.

Camorlinga-Ponce M, Romo C, Gonzalez-Valencia G, Munoz O, Torres J . Topographical localisation of cagA positive and cagA negative Helicobacter pylori strains in the gastric mucosa; an in situ hybridisation study. J Clin Pathol. 2004; 57(8):822-8. PMC: 1770390. DOI: 10.1136/jcp.2004.017087. View

12.

Jakubovics N, Stromberg N, van Dolleweerd C, Kelly C, Jenkinson H . Differential binding specificities of oral streptococcal antigen I/II family adhesins for human or bacterial ligands. Mol Microbiol. 2005; 55(5):1591-605. DOI: 10.1111/j.1365-2958.2005.04495.x. View

13.

Wada A, Mori N, Oishi K, Hojo H, Nakahara Y, Hamanaka Y . Induction of human beta-defensin-2 mRNA expression by Helicobacter pylori in human gastric cell line MKN45 cells on cag pathogenicity island. Biochem Biophys Res Commun. 1999; 263(3):770-4. DOI: 10.1006/bbrc.1999.1452. View

14.

Fellermann K, Stange D, Schaeffeler E, Schmalzl H, Wehkamp J, Bevins C . A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet. 2006; 79(3):439-48. PMC: 1559531. DOI: 10.1086/505915. View

15.

Sarrias M, Gronlund J, Padilla O, Madsen J, Holmskov U, Lozano F . The Scavenger Receptor Cysteine-Rich (SRCR) domain: an ancient and highly conserved protein module of the innate immune system. Crit Rev Immunol. 2004; 24(1):1-37. DOI: 10.1615/critrevimmunol.v24.i1.10. View

16.

Stecher B, Robbiani R, Walker A, Westendorf A, Barthel M, Kremer M . Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 2007; 5(10):2177-89. PMC: 1951780. DOI: 10.1371/journal.pbio.0050244. View

17.

Liu L, Roberts A, Ganz T . By IL-1 signaling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide. J Immunol. 2002; 170(1):575-80. DOI: 10.4049/jimmunol.170.1.575. View

18.

Reyes-Leon A, Atherton J, Argent R, Puente J, Torres J . Heterogeneity in the activity of Mexican Helicobacter pylori strains in gastric epithelial cells and its association with diversity in the cagA gene. Infect Immun. 2007; 75(7):3445-54. PMC: 1932923. DOI: 10.1128/IAI.01951-06. View

19.

Bik E, Eckburg P, Gill S, Nelson K, Purdom E, Francois F . Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A. 2006; 103(3):732-7. PMC: 1334644. DOI: 10.1073/pnas.0506655103. View

20.

Liu L, Wang L, Jia H, Zhao C, Heng H, Schutte B . Structure and mapping of the human beta-defensin HBD-2 gene and its expression at sites of inflammation. Gene. 1998; 222(2):237-44. DOI: 10.1016/s0378-1119(98)00480-6. View